MedTrace Logo

A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department

NCT00429832 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-02-01

No results posted yet for this study

Summary

This was a trial comparing two commonly used medications for nausea and vomiting, ondansetron and promethazine, in the Emergency Department.

Conditions

Interventions

DRUG

Ondansetron

DRUG

promethazine

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Darren A Braude, MD, MPH · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00429832 on ClinicalTrials.gov